229 related articles for article (PubMed ID: 16537454)
1. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase.
Collins CS; Hong J; Sapinoso L; Zhou Y; Liu Z; Micklash K; Schultz PG; Hampton GM
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3775-80. PubMed ID: 16537454
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
3. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF
Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204
[TBL] [Abstract][Full Text] [Related]
4. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
6. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
7. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
8. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
9. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
Yang N; Wang Y; Hui L; Li X; Jiang X
J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
Yang HS; Matthews CP; Clair T; Wang Q; Baker AR; Li CC; Tan TH; Colburn NH
Mol Cell Biol; 2006 Feb; 26(4):1297-306. PubMed ID: 16449643
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
12. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
13. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
Guo K; Liu Y; Zhou H; Dai Z; Zhang J; Sun R; Chen J; Sun Q; Lu W; Kang X; Chen P
Cancer Sci; 2008 Mar; 99(3):486-96. PubMed ID: 18167130
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
[TBL] [Abstract][Full Text] [Related]
15. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration.
Okada Y; Saika S; Shirai K; Yamanaka O; Kitano A; Wang Z; Yang H; Reinach P
Ophthalmic Res; 2009; 42(4):185-92. PubMed ID: 19672126
[TBL] [Abstract][Full Text] [Related]
16. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
17. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; IƱiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
19. The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
Roovers K; Wagner S; Storbeck CJ; O'Reilly P; Lo V; Northey JJ; Chmielecki J; Muller WJ; Siegel PM; Sabourin LA
Oncogene; 2009 Aug; 28(31):2839-48. PubMed ID: 19525980
[TBL] [Abstract][Full Text] [Related]
20. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
Yang L; Dan HC; Sun M; Liu Q; Sun XM; Feldman RI; Hamilton AD; Polokoff M; Nicosia SV; Herlyn M; Sebti SM; Cheng JQ
Cancer Res; 2004 Jul; 64(13):4394-9. PubMed ID: 15231645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]